Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Timex Contract Win

14 Jun 2006 07:00

Embargoed Release: 07:00hrs Wednesday 14th June 2006 Sopheon Plc (`Sopheon') Timex Advances Innovation Strategy with Sopheon's Accolade System Leading Watchmaker Up and Running with Best-Practice Product Innovation Process in Only 60 Days Sopheon, the international software and services company, is pleased toannounce that Timex Corporation, the largest-selling wristwatch brand inAmerica, has deployed Sopheon's Accolade as its product innovation process andproduct portfolio management solution. Timex recently completed enterprise-wideimplementation of the system across all departments and to executive managementin a rollout that took approximately 60 days.Connecticut-based Timex was founded in 1854. It sells more than 30 millionwatches annually. The privately held company employs 7500 people at facilitieslocated in the U.S., South America, Europe and Asia.Timex operates in a fiercely competitive industry where ever-shorter productlife cycles have made continuous technology innovation critical to marketsuccess. Faced with the emergence of alternative timekeeping devices such ascell phones, PDAs and computers, Timex has continued to innovate and evolve itscore lines while expanding its product portfolio to include multi-functionwrist pagers, compasses, heart monitors and thermometers.Timex's implementation of Sopheon's Accolade system is integral to thecompany's adoption of Stage-Gate, the widely used product developmentmethodology. Accolade is being used to automate the Stage-Gate process and toprovide decision-making support for management of the company's increasinglycomplex portfolio of products. A primary reason Timex selected the Sopheonsolution is that it is specifically designed to support stage- or phase-basedproduct development processes and has proven capacity to strengthen processgovernance and throughput. Other considerations included the software'sease-of-use, its simple configurability and the speed with which it can beimplemented"We set a very aggressive timetable for our rollout of Accolade," said BerndBecker, vice president of product development at Timex. "Given the complexityof the implementation and the level of configuration required, I never expectedthat Sopheon would finish on time. But they did-in just two months and with nostart-up issues. Some of the first reactions to Accolade came from seniormanagement. They were immediately impressed by the level of detailedinformation the system gave them, and the ease with which that informationcould be accessed. With Accolade in place across our organization, we are doinga better job of managing our R&D investments, and we are fully realizing thebenefits of Stage-Gate. Sopheon and Accolade were clearly the right choice.""Most of the companies we deal with have identified innovation as a topstrategic priority and are acting with urgency," said Andy Michuda, chiefexecutive officer of Sopheon. "We give our clients the advantage of a systemthat is easy to implement, and customer service support that emphasizes workingsmart and fast without a lot of involvement by internal IT to deliver asolution that maps precisely to the adopting organization's requirements. Timexhad a clearly defined process and was very savvy about what they wanted toaccomplish through our software. As a result, we were able to hit the groundrunning and, working closely with their team, put a fully automated,world-class innovation system in place in a matter of weeks. For the client,this translates into accelerated time-to-value and a sustainable source ofimportant competitive advantage."Sopheon Accolade‚® is a registered trademark of Sopheon plc.Timex is a registered trademark of the Timex Corporation.Stage-Gate is a registered trademark of the Product Development Institute.All other trademarks and registered trademarks are the soleproperty of their respective owners.About TimexFounded in 1854, Timex is a privately owned company with manufacturing plantsand company offices in over 80 countries around the world. With more thanone-billion watches bearing the Timex brand sold world-wide, the TimexCorporation has been providing innovative, well-designed, and reliabletimepieces for over 150 years. For more information, please visit www.timex.comAbout SopheonSopheon (LSE: SPE) is an international provider of software and services thathelp organizations improve the business impact of product innovation. TheSopheon Accolade‚® product innovation process and portfolio management systemautomates gate- or phase-based product development processes and providesstrategic decision support that allows companies to increase revenue andprofits from new products. Sopheon is listed on the AIM Market of the LondonStock Exchange and on the Euronext in the Netherlands. For more information,please visit www.sopheon.com.Barry Mence, Chairman Sopheon plc Tel : + 44 (0) 1483 685 735 Arif Karimjee, CFO Andrew Tan Hansard Communications Tel : + 44 (0) 207 245 1100 + 44 (0) 7957 203 685 Frank Jansen Citigate First Financial Tel : + 31 (0) 205 754 010ENDSOPHEON PLC
Date   Source Headline
3rd Nov 202310:15 amRNSForm 8.5 (EPT/NON-RI)
3rd Nov 20238:54 amRNSForm 8.3 - Rivomore Limited - Sopheon plc
2nd Nov 20239:34 amRNSForm 8.5 (EPT/NON-RI)
1st Nov 20233:44 pmEQSForm 8.3 - Apex Fundrock Limited : Form 8.3 Apex Fundrock Limited Re: Sopheon PLC
1st Nov 20231:55 pmRNSForm 8.3 - Sopheon plc
1st Nov 202311:23 amRNSForm 8.5 (EPT/NON-RI)
1st Nov 202310:51 amGNWForm 8.3 - [Sopheon plc - Opening Declaration - 31 03 2023] - (CGAML)
1st Nov 202310:35 amRNSForm 8.3 - Sopheon PLC
31st Oct 20231:00 pmRNSStatement re Possible Offer
24th Aug 20237:00 amRNSInterim Results
10th Jul 20237:00 amRNSAcquisition
15th Jun 20235:06 pmRNSIssue of Equity
8th Jun 20231:35 pmRNSResult of AGM
8th Jun 20237:00 amRNSAGM Statement
13th Apr 20234:20 pmRNSIssue of Equity
31st Mar 20239:14 amRNSIssue of Equity
27th Mar 20234:23 pmRNSDirector Shareholdings
24th Mar 20237:00 amRNSDirector Share Purchases
23rd Mar 20237:00 amRNSFinal Results
22nd Feb 20234:59 pmRNSIssue of Equity
6th Feb 20237:00 amRNSDirectorate Change and Notice of Results
30th Jan 20237:00 amRNSTrading Update
20th Sep 202212:01 pmRNSSopheon launches Acclaim Line of SaaS Offerings
2nd Sep 202210:06 amRNSIssue of Equity
1st Sep 20227:00 amRNSNew Release of Award-winning Innovation Product
24th Aug 20227:00 amRNSInterim Results
16th Aug 20227:00 amRNSFive-year, $11.2m Enterprise Agreement
3rd Aug 202210:18 amRNSHolding(s) in Company
21st Jun 202212:20 pmRNSHolding(s) in Company
9th Jun 20222:30 pmRNSResult of AGM
9th Jun 20227:00 amRNSAGM Statement
6th Jun 20226:02 pmRNSIssue of Equity & TVR
23rd May 20227:00 amRNSDirector Dealing & Issue of Equity
18th May 20227:00 amRNSAcquisition
29th Apr 20225:12 pmRNSHolding(s) in Company
7th Apr 20227:00 amRNSNew Sopheon Software Release
1st Apr 202212:10 pmRNSDirector Shareholdings
24th Mar 20227:00 amRNSFinal Results
25th Jan 20227:00 amRNSTrading Update
17th Jan 20223:15 pmRNSIssue of Equity
20th Dec 20217:00 amRNSAcquisition and Trading Update
24th Sep 20211:52 pmRNSIssue of Equity
16th Sep 202110:00 amRNSHolding(s) in Company
13th Sep 20215:24 pmRNSIssue of Equity
31st Aug 20216:14 pmRNSDirector Shareholdings
25th Aug 20217:00 amRNSInterim Results
13th Jul 20217:00 amRNSNew Release Drives Business Transformation
23rd Jun 20217:00 amRNSSopheon Earns Authority to Operate for NAVSEA
15th Jun 20219:54 amRNSIssue of Equity
10th Jun 202111:43 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.